Gothenburg-based Swedish company supplying products and services for in vitro fertilization (IVF) clinics and laboratories.
Founded in 1994 and headquartered in Gothenburg, Sweden, Vitrolife AB makes products for in vitro fertilization. Its offerings include the EmbryoScope+ time-lapse system, IVF media and oils, and tools such as oocyte retrieval needles, micromanipulation pipettes and genomic kits. CEO Amelie Wilson leads the company, which reported revenues of USD 320.79 mn and EBITDA of USD 104.15 mn for fiscal 2022. EQT acquired a minority stake in June 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in